Comparing clinical outcomes of NOACs with warfarin on atrial fibrillation with Valvular heart diseases: a meta-analysis

Comparing clinical outcomes of NOACs with warfarin on atrial fibrillation with Valvular heart diseases: a meta-analysis

Abstract Background Warfarin is the standard of care and NOAC (Novel oral anticoagulants) are a group of newer drugs for such purposes. NOAC has a generally better profile (Clear interaction, less side effect, require less monitoring). However, its efficacy on valvular atrial fibrillation remains un...

Full description

Bibliographic Details
Main Authors: Qiyu He, Chun-Yat Sze, Tin-Yau Shum, Guang Hao, Nga-Yin Belinda Wong, Tat-Hang Sin, Wei Wei, Sujian Xia
Format: Article
Language:English
Published: BMC 2019-05-01
Series:BMC Cardiovascular Disorders
Subjects:
Meta-analysis
NOAC
Warfarin
Atrial fibrillation
Valvular heart disease
Online Access:http://link.springer.com/article/10.1186/s12872-019-1089-0

Internet

http://link.springer.com/article/10.1186/s12872-019-1089-0

Similar Items